Elsevier

Psychoneuroendocrinology

Volume 74, December 2016, Pages 397-405
Psychoneuroendocrinology

Relationship between hair and salivary cortisol and pregnancy in women undergoing IVF

https://doi.org/10.1016/j.psyneuen.2016.08.027Get rights and content

Highlights

  • Both acute salivary cortisol and long term cortisol obtained from hair were assessed in women undergoing infertility treatment.

  • Acute salivary cortisol levels did not predict clinical pregnancy.

  • Chronic cortisol as measured in hair significantly predicted clinical pregnancy whilst controlling for covariates.

Abstract

Evidence for an association between cortisol and clinical pregnancy in women undergoing In Vitro Fertilisation (IVF) is mixed with previous studies relying exclusively on short term measures of cortisol in blood, saliva, urine, and/or follicular fluid. Hair sampling allows analysis of systemic levels of cortisol over the preceding 3–6 months. The present study sought to explore the relationship between cortisol and clinical pregnancy outcome in women undergoing IVF utilising multiple indices of cortisol derived from both saliva and hair measured prior to commencing gonadotrophin treatment. A total of 135 women (mean age 34.5 SD +/−4.8) were recruited from an English fertility clinic (December 2012–April 2014) 60% of whom became pregnant (n = 81). Salivary cortisol data were obtained over two days: upon awakening, 30 min post awakening, and at 22:00. A subsample (n = 88) of the women providing salivary samples were approached consecutively to provide hair samples for the measurement of cortisol. Independent Logistic regression analyses revealed that salivary cortisol measures including cortisol awakening response (CAR) (p = 0.485), area under the curve with respect to ground (AUCg) (p = 0.527), area under the curve with respect to increase (AUCi) (p = 0.731) and diurnal slope (p = 0.889) did not predict clinical pregnancy. In contrast, hair cortisol concentrations significantly predicted clinical pregnancy (p = 0.017). Associations between hair cortisol and clinical pregnancy remained when controlling for accumulations of salivary cortisol (p = 0.034) accounting for 26.7% of the variance in pregnancy outcome.

These findings provide preliminary evidence that longer term systemic cortisol may influence reproductive outcomes; and in turn suggests that interventions to reduce cortisol prior to commencing IVF could improve treatment outcomes.

Introduction

The role that stress may exert on reproductive functioning has remained a topic of debate for decades (Boivin and Venetis, 2011, Matthiesen et al., 2011). This debate has been fuelled not least by the complexities of delineating plausible psychobiological pathways by which stress might influence reproductive outcomes (Whirledge and Cidlowski, 2010, Toufexis et al., 2014). Two main pathways have been considered: the hypothalamic pituitary adrenal (HPA) − hypothalamic pituitary gonadal (HPG) axis and the HPA − immune axis. The glucocorticoid cortisol, the main effector of the HPA axis, plays a central role in both pathways. With regard to the HPA-HPG pathway, elevated cortisol has been shown to inhibit sexual functions at all three levels of the HPG axis. At the level of the hypothalamus via inhibition of gonadotrophin releasing hormone (GnRh) secretion (Dubey and Plant, 1985, Kamel and Kubajak, 1987), at the level of the pituitary by interfering with GnRh induced luteinising hormone release (Briski and Sylvester, 1991), and at the level of the gonads by altering the stimulatory effect of gonadotrophins on sex steroid secretion (Bambino and Hsueh, 1981, Hsueh and Erikson, 1978).

With regard to the HPA-immune pathway it is well established that cortisol can regulate the activity of the immune system (Tsigos and Chrousos, 2002), including effects on the production of proinflammatory cytokines, tumour necrosis factor (TNF) and natural killer (NK) cell activity (Gatti et al., 1987, Mavoungou, 2006) all of which have been implicated in reproductive outcomes (Daher et al., 1999). However, the precise role of the immune system in pregnancy continues to be an area of debate. Taking the early phases of pregnancy as an example, it has been suggested that because the fetus is semi-allogenic to the maternal host, that a degree of immune suppression may favour conception (Thornton, 2010, Nepomnaschy et al., 2007). In contrast, it has been argued that, rather than immune suppression, a strong inflammatory response is required for conception to occur (Mor, 2011). These competing views are likely to be due, in part, to the fact that as observed by Mor, (2011), pregnancy has often been conceptualised as a single immunological event. However, there is evidence that it consists of three distinct phases (characterised by a pro-inflammatory (first trimester), anti-inflammatory (second trimester) and then finally a return to a pro-inflammatory state (third trimester). Furthermore, as noted by Christian (2015), even though the immune system is highly regulated by the neuroendocrine system, to date, there has been little integration of these literatures in the context of fertility and pregnancy: further impeding attempts to delineate the significance of the HPA-immune pathway.

These contrasting views regarding the role of the immune system during conception are further complicated by the presence or absence of glucocorticoid resistance (GR). GR refers to the phenomenon whereby immune function fails to downregulate despite the presence of chronically elevated cortisol (Cohen et al., 2012, Barnes and Adcock, 2009). Thus, two scenarios are possible. In the first, elevated cortisol results in immunosuppression (in the absence of GR). In the second, elevated cortisol (in the presence of GR) fails to down regulate inflammatory responses (Nepomnaschy et al., 2007, Thornton, 2010). These opposing effects of cortisol on immunity have fuelled the debate about the role of the immune system in fertility and specifically whether and when immune suppression, normal immune function or indeed heightened immune activity promotes or hinders reproductive outcomes.

Given what is understood about the direct effects of the HPA-HPG axis on reproduction, and the proposed role that immunosuppression may or may not play, divergent effects on pregnancy outcomes could be expected in women undergoing infertility treatment. Considering, for example, just the period prior to commencing treatment, increased cortisol, from the perspective of the HPA-HPG (and potentially also the HPA-immune axis in the presence of GR and excessive inflammation) could be expected to be associated with decreased likelihood of pregnancy. In contrast, from the perspective of an HPA-immune pathway (in the absence of GR), advocates of the view that immune suppression favours conception (e.g., Thornton, 2010, Nepomnaschy et al., 2007) may expect greater levels of cortisol to be associated with an increased likelihood of pregnancy. These contrasting outcomes were evident in a recent systematic review which reported that both high and low cortisol levels were associated with an increased likelihood of pregnancy in women undergoing IVF treatment (Massey et al., 2014). Twelve studies were identified that explored associations between cortisol (measured in blood, urine, saliva and follicular fluid) and establishment of clinical pregnancy. Three studies reported significant associations between elevated cortisol in follicular fluid and increased likelihood of clinical pregnancy (Andersen and Hornnes, 1994, Keay et al., 2002, Thurston et al., 2003). Four studies showed the opposite relationship albeit at different stages of treatment (Demyttenaere et al., 1992, Micheal et al., 1999, An et al., 2011, An et al., 2013). The remaining five studies failed to find any significant associations between cortisol and pregnancy outcomes (Lovely et al., 2003, Lewicka et al., 2003, Smeenk et al., 2005, Nouri et al., 2011, Csemiczky et al., 2000). These equivocal findings are in contrast to evidence from animal studies which have shown a more consistent relationship between elevated cortisol levels and impaired reproductive outcomes across a range of species (Dobson and Smith, 1995, Alejandro et al., 2014).

A number of methodological factors may have contributed to the findings in this review. First, the majority of studies failed to control for extraneous variables known to influence cortisol including time of day, caffeine consumption and body mass index (BMI) (Massey et al., 2014). Second, studies measured cortisol at different stages of treatment. Whilst IVF is a useful clinical model for exploring the effects of stress on reproductive outcomes, over half of the studies (7/12) measured cortisol following gonadotrophin administration (Andersen and Hornnes, 1994, Keay et al., 2002, Thurston et al., 2003, Micheal et al., 1999, Lovely et al., 2003, Lewicka et al., 2003, Nouri et al., 2011). Gonadotrophins have profound effects on the HPA axis and, therefore, are likely to have confounded any observed associations between HPA function and pregnancy. Third, studies relied exclusively on acute (saliva, blood) or short term (urine, follicular fluid) measures of cortisol. However, these measures are only able to provide information about cortisol levels over minutes (saliva/blood) to hours (urine/follicular fluid). At best, such measures may not accurately represent basal function or, at worst, may only capture transient levels of the hormone which are unlikely to influence health (Saxbe, 2008).

A recent methodological development that may prove promising for understanding HPA function is hair sampling which provides a retrospective index of cumulative cortisol exposure over extended periods of 3–6 months (Gow et al., 2010). The validity and reliability of hair cortisol sampling has been supported in both animal (Davenport et al., 2006) and human studies (Sauve et al., 2007, Stalder and Kirschbaum, 2012). Furthermore, the utility of hair sampling as a marker of long term HPA function has been demonstrated in a range of health contexts (Yamada et al., 2007, Kalra et al., 2007, Dettenborn et al., 2011, Steudte et al., 2011, Pereg et al., 2011, Braig et al., 2015).

The aim of this study was, therefore, to build upon previous work by exploring the relationship between acute (saliva) and chronic (hair) cortisol measured in the 1–2 weeks prior to commencing IVF treatment and treatment outcomes, as measured by the absence/presence of a clinical pregnancy. In view of the continued uncertainty regarding the precise role of the HPA-immune pathway in reproductive outcomes, we hypothesised that, in support of the HPA-HPG pathway elevated levels of acute and chronic cortisol would be associated with a reduced likelihood of pregnancy.

Section snippets

Recruitment

Recruitment took place at a single English fertility clinic between December 2012 to April 2014. Non-smoking women, with a body mass index (BMI) of 19–35, undergoing a long GnRH agonist protocol were eligible for participation. Study exclusion criteria included subjects with any recognised endocrinological health conditions (Kudielka et al., 2009). Patients taking concurrent corticosteroids were excluded from recruitment. Eligible patients received information regarding the study along with

Comparing participants and non-participants on demographic and clinical variables

Independent sample t-tests were conducted to compare patients providing salivary and or hair cortisol data (n = 135) and the original sample who were recruited (n = 190). For all measures, no statistically significant differences were evident between these groups on age, number of years infertile, number of previous attempts, fertilisation rate (%), number of oocytes or BMI (all p’s > 0.05: data not shown).

Patient/treatment demographics and levels of cortisol

The mean age of the participants was 34 years (mean 34.5 SD 4.8). The study sample comprised of

Discussion

To our knowledge, this is the first study to explore associations between both acute and chronic measures of cortisol exposure on the outcome of IVF. We examined whether levels of cortisol prior to IVF treatment were associated with the likelihood of clinical pregnancy. Measures of salivary cortisol (CAR, AUCg, AUCi and diurnal slope) did not predict clinical pregnancy. However, hair cortisol concentrations did, with greater levels associated with a reduced likelihood of conception. Our

Conflicts of interest

None.

Contributions

All authors contributed to the design of the study. Adam Massey collected the data. Adam Massey and Jane Perry analysed the data. Catherine Pinicott-Allen and Adam Massey analysed hair samples. Adam Massey, Bruce Campbell, Nick Raine-Fenning, Jane Perry and Kavita Vedhara wrote the paper. All authors have approved the final article.

Role of the funding source

NURTURE fertility funded the project but did not play a role in the study design; collection, analysis or interpretation of data, in the writing of the report or in the decision to submit the article for publication.

Acknowledgements

None.

References (64)

  • K. Nouri et al.

    Saliva cortisol and subjective stress are not associated with number of oocytes after controlled ovarian hyper stimulation in patients undergoing in vitro fertilization

    Fertili. Steril.

    (2011)
  • J.C. Pruessner et al.

    Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time dependant change

    Psychoneurendocrinology

    (2003)
  • J.S. Raul et al.

    Detection of physiological concentrations of cortisol and cortisone in human hair

    Clin. Biochem.

    (2004)
  • E. Russell et al.

    Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions

    Pyshoneuroendocrinology

    (2012)
  • S.M. Staufenbiel et al.

    Determinants of hair cortisol and hair cortisone concentrations in adults

    Psychoneuroendocrinology

    (2015)
  • S. Steudte et al.

    Decreased hair cortisol concentrations in generalized anxiety disorder

    Psychiatry Res.

    (2011)
  • L. Thorn et al.

    Suspected non-adherence and weekend versus week day differences in the awakening cortisol response

    Psychoneuroendocrinology

    (2006)
  • K. Vedhara et al.

    Psychosocial factors associated with indices of cortisol production in women with breast cancer and controls

    Psychoneuroendocrinology

    (2006)
  • R. Wennig

    Potential problems with the interpretation of hair analysis results

    Forensic Sci. Int.

    (2000)
  • J.O. Younge et al.

    Cortisol levels in scalp hair of patients with structural heart disease

    Int. J. Cardiol.

    (2015)
  • C.I. Alejandro et al.

    Environmental stress effect on animal reproduction

    Open J. Anim. Sci.

    (2014)
  • Y. An et al.

    Relationship between psychological stress and reproductive outcome in women undergoing in vitro fertilisation treatment: psychological and neurohormonal assessment

    J. Assist. Reprod. Genet.

    (2013)
  • C.Y. Andersen et al.

    Intrafollicular concentrations of free cortisol close to follicular rupture

    Hum. Reprod.

    (1994)
  • T.H. Bambino et al.

    Direct inhibitory effect of glucocorticoids upon testicular luteinising hormone receptor and steroidogenesis in vivo and in vitro

    Endocrinology

    (1981)
  • J. Boivin et al.

    Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies

    Br. Med. J.

    (2011)
  • K.P. Briski et al.

    Acute inhibition of pituitary LH release in the male rat by the glucocorticoids agonist decadron phosphate

    Neuroendocrinology

    (1991)
  • L.M. Christian

    Stress and immune function during pregnancy: an emerging focus in mind-body medicine

    Curr. Dir. Psychol. Sci.

    (2015)
  • A. Clow et al.

    The cortisol awakening response: more than a measure of HPA axis function

    Neurosci. Biobehav. Rev.

    (2009)
  • S. Cohen et al.

    Chronic stress, glucocorticoid receptor resistance, inflammation and disease risk

    Proc. Natl. Acad. Sci. U. S. A.

    (2012)
  • J. Cohen

    Statistical Power Analysis for the Behavioral Sciences

    (1988)
  • G. Csemiczky et al.

    The influence of stress and state anxiety on the outcome of IVF treatment. Psychological and endocrinological assessment of Swedish women entering IVF treatment

    Acta Obstet. Gynecol. Scand.

    (2000)
  • L. Dettenborn et al.

    Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression

    Stress

    (2011)
  • Cited by (0)

    View full text